FIELD: medicine.
SUBSTANCE: invention can be used in the treatment of patients with severe forms of reperfusion syndrome after reconstructive surgical interventions on the arteries of the lower extremities. The treatment is carried out in three stages: at the first stage of treatment, a plasmapheresis session is used for 10 days. Next, Longidaza 3,000 IU is administered, it is dissolved in 1.0–2.0 ml of 0.5% Novocaine solution and injected in the first interdigital space once, Phlebodia 600 mg 2 tablets in the morning orally, Clopidogrel 75 mg per day, ThromboAss 100 mg per day, Rivaroxaban 2.5 mg 2 times a day orally, Sulodexide 600 LE intravenous drip and Actovegin 10 ml intravenous drip, Neuromultivit 2 ml intramuscularly once a day, class 2 elastic compression of the lower extremities — elastic stockings, individually selected in size or elastic bandages and elevated position of the limb on a splint. At the second stage of treatment lasting 10 days, elastic compression of the lower extremities of class 2 is still used, and the following medicinal products are used: ThromboAss 100 mg per day, Clopidogrel 75 mg 1 tablet once a day, Rivaroxaban 2.5 mg 1 tablet 2 times a day, Phlebodia 600 mg 1 tablet 1 time a day in the morning, Sulodexide 600 LE intramuscularly once a day, Neuromultivit 1 tablet 3 times a day, Actovegin 5 ml intramuscularly 1 time a day. At the third stage, elastic compression of the lower extremities of class 2 is still used, and the following disaggregants are used: ThromboAss 100 mg 1 tablet once a day, Clopidogrel 75 mg 1 tablet once a day, Rivaroxaban 2.5 mg 1 tablet 2 times a day for 12 months, Phlebodia 600 mg 1 tablet once a day in the morning for 3 months, Sulodexide 250 LE 1 capsule 2 times a day orally for 2 months, Neuromultivitis 1 tablet 3 times a day orally for 1 month, Actovegin 2 capsules 3 times a day orally for 4 months.
EFFECT: invention makes it possible to reduce or completely eliminate reperfusion edema of the operated lower limb and shorten the treatment time.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH REPERFUSION SYNDROME | 2023 |
|
RU2807876C1 |
METHOD OF TREATING PATIENTS WITH POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2807874C1 |
METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME COMPLICATED BY POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2808921C1 |
METHOD FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOSIS AFTER THE NOVEL CORONAVIRUS INFECTION | 2022 |
|
RU2791373C1 |
METHOD FOR CORRECTION OF THROMBOPHILIC DISORDERS ACCOMPANYING PREGNANCY | 2012 |
|
RU2524653C1 |
METHOD OF TREATING REPERFUSION SYNDROME IN PATIENTS WITH DIABETES MELLITUS FOLLOWING RE-VASCULARISATION OF LOWER EXTREMITY ARTERIES | 2014 |
|
RU2548739C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ACUTE THROMBOPHLEBITIS OF SUPERFICIAL VEINS OF LOWER EXTREMITIES | 2021 |
|
RU2759653C1 |
METHOD OF TREATING CHRONIC ARTERIAL INSUFFICIENCY | 2007 |
|
RU2372088C2 |
METHOD FOR CARE OF PATIENTS WITH ACUTE CORONARY SYNDROME UNDER CONDITIONS OF MEDICAL INSTITUTION WITH SPECIALIZED DEPARTMENT OF PERCUTANEOUS CORONARY INTERVENTIONS | 2015 |
|
RU2641851C2 |
METHOD OF COMPLEX TREATMENT OF PATIENTS WITH PURULONECROTIC COMPLICATIONS OF DIABETIC FOOT SYNDROME | 2020 |
|
RU2737491C1 |
Authors
Dates
2023-11-21—Published
2023-08-01—Filed